pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
diranersen · news · pharmadog
← back to diranersen
News mentioning diranersen
11
stories
11d
Biogen’s targeted ALS treatment is reversing decline in some patients. Can more be helped?
biospace
22d
Biogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the store
biospace
22d
Biogen shifts M&A strategy as Apellis acquisition pushes revenue above analyst expectations
biospace
22d
‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a while
fiercebiotech
Jul 15, 26
STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and more
stat
Jul 14, 26
STAT+: Biogen Alzheimer’s drug slowed decline at rates on par with approved therapies, study shows
stat
Jul 14, 26
Biogen data highlight promise, questions surrounding tau-targeting Alzheimer’s drugs
biopharma dive
Jul 1, 26
STAT+: The biotech scorecard for the third quarter: 15 stock-moving events to watch
stat
May 14, 26
Biogen pushing tau drug forward despite Alzheimer’s study failure
biopharma dive
May 14, 26
STAT+: Pharmalittle: We’re reading about upbeat results for a Duchenne drug, Takeda layoffs, and much more
stat
May 14, 26
STAT+: Biogen’s tau-targeting Alzheimer’s drug posts mixed results in mid-stage study
stat
